文献速递运动医学关节外科

术中单剂量唑来膦酸改善肩袖修复腱骨愈合的循环miRNA机制

Intraoperative Zoledronic Acid for Arthroscopic Rotator Cuff Repair Results in Distinct Circulating Micro-RNA Profiles Indicating Improved Tendon-to-Bone Healing.
PubMed 文献 · Am J Sports Med · 2026-06-18

基于一项单中心、前瞻性、随机、安慰剂对照、三盲II期试验(80例非骨质疏松肩袖修复患者),术中随机给予单剂量唑来膦酸(n=40)或对照(n=40),采用小RNA测序和RT-qPCR检测术前、术后2天及术后3月循环血浆miRNA。结果显示唑来膦酸组术后2天miR-140-3p显著降低,对照组术后2天miR-29a-3p、miR-21-5p、miR-192-5p、miR-146a-5p显著降低,术后3月两组趋于一致。

要点

  • 唑来膦酸组术后2天miR-140-3p血浆水平显著低于对照(P = .047)。
  • 对照组术后2天miR-29a-3p(P < .001)、miR-21-5p(P = .036)、miR-192-5p(P = .034)、miR-146a-5p(P < .001)显著降低。
  • 术后3月两组miRNA水平无显著差异,提示分子应答具有时间特征。

核心结论

  • 纵向血浆miRNA表达提示机体对唑来膦酸存在分子应答,可能反映止点炎症与纤维化减少、胶原合成与血管化增加,从而可能解释腱骨愈合改善。

研究设计与样本

  • 研究为单中心、前瞻性、随机、安慰剂对照、三盲(研究者、外科医生、患者)II期试验框架下的对照实验室研究。
  • 共80例接受关节镜肩袖修复的患者术中随机分为唑来膦酸组(n = 40)与对照组(n = 40)。
  • 采用小RNA测序与逆转录定量聚合酶链反应(RT-qPCR)检测术前、术后2天及术后3月循环血浆miRNA。

主要发现

  • 基于小RNA测序分析选出6个miRNA用RT-qPCR验证。
  • 术前两组miRNA血浆水平无统计学差异。
  • 术后2天唑来膦酸组miR-140-3p血浆水平显著降低(P = .047)。
  • 对照组术后2天miR-29a-3p(P < .001)、miR-21-5p(P = .036)、miR-192-5p(P = .034)、miR-146a-5p(P < .001)血浆水平显著降低。
  • 术后3月两组miRNA血浆水平趋于一致,无显著差异。

关键数值与推荐

  • 唑来膦酸组术后2天miR-140-3p差异P = .047。
  • 对照组术后2天miR-29a-3p P < .001、miR-21-5p P = .036、miR-192-5p P = .034、miR-146a-5p P < .001。
  • 试验注册号NCT05677152。

临床怎么用

  • 唑来膦酸被视为关节镜肩袖修复患者安全且易于实施的增强技术。
  • 循环miRNA谱可作为观察唑来膦酸分子应答的纵向指标,但临床应用仍需进一步验证。

局限性

  • 为II期试验框架下的对照实验室研究,样本量共80例,miRNA结论基于6个验证miRNA。
  • 术后3月两组miRNA水平已无显著差异,观察期较短。
  • 分子机制为靶点分析推测,未直接证实临床愈合改善的因果路径。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A prospective, randomized, placebo-controlled trial showed reduced retears after arthroscopic rotator cuff (RC) repair in patients without osteoporosis by a systemic single-dose of zoledronic acid. Distinct micro-ribonucleic acids (miRNAs) related to inflammation, fibrosis, and tendon-to-bone healing are associated with RC injuries. PURPOSE: To investigate the longitudinal effects of a single-dose of zoledronic acid in patients without osteoporosis undergoing arthroscopic RC repair on circulating miRNAs in order to explore the molecular mechanism of this treatment. STUDY DESIGN: Controlled laboratory study. METHODS: Data were collected in the course of a single-center, prospective, randomized, placebo-controlled, triple-blinded (investigator, surgeon, patient) phase II trial. A total of 80 patients underwent arthroscopic RC repair and were intraoperatively randomized to the zoledronic acid group (n = 40) or the control group (n = 40). Circulating plasma miRNAs were assessed preoperatively, 2 days postoperatively, and 3 months postoperatively using small RNA sequencing and reverse transcription quantitative polymerase chain reaction (RT-qPCR). RESULTS: Six miRNAs were selected for validation by RT-qPCR based on small RNA-sequencing analysis. No statistical differences in miRNA plasma levels were observed preoperatively between the 2 study groups. Two days after surgery, plasma levels were significantly lower for miR-140-3p (P = .047) in the zoledronic acid group. In the control group, plasma levels were significantly lower for miR-29a-3p (P < .001), miR-21-5p (P = .036), miR-192-5p (P = .034), and miR-146a-5p (P < .001) 2 days after surgery. Three months after surgery, miRNA plasma levels of the 2 study groups equalized without any significant differences. Gene target analysis identified collagen type I alpha 1 chain, collagen type III alpha 1 chain, vascular endothelial growth factor, insulin-like growth factor 1, and transforming growth factor-β1 as targets of miRNAs impacted by zoledronic acid. CONCLUSION: Longitudinal plasma miRNA expressions suggest a molecular response to zoledronic acid, potentially indicating a reduction of inflammation and fibrosis at the enthesis as well as increased collagen synthesis and vascularization, possibly explaining improved tendon-to-bone healing. CLINICAL RELEVANCE: Zoledronic acid is a safe and easy-to-apply augmentation technique for patients undergoing arthroscopic RC repair. REGISTRATION: NCT05677152 (ClinicalTrials.gov identifier).

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Schanda JE, Hackl M, Bischl R, et al. Intraoperative Zoledronic Acid for Arthroscopic Rotator Cuff Repair Results in Distinct Circulating Micro-RNA Profiles Indicating Improved Tendon-to-Bone Healing. Am J Sports Med. 2026. PMID: 42316896. doi:10.1177/03635465261455031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。